2024-09-03 - Analysis Report
## Lilly (LLY) Stock Analysis

**Company Overview:** Lilly is a leading pharmaceutical company, known for its innovative drug development and diverse portfolio of products.

**1. Performance vs. S&P 500 (VOO):**

* **LLY's Cumulative Return:** 571.94%
* **VOO's Cumulative Return:** 89.66%
* **Relative Divergence:** 482.28 (100% on the scale)

LLY has significantly outperformed the S&P 500 (VOO) over the period considered.  Currently, LLY's cumulative return is 482.28% higher than the S&P 500, representing the maximum divergence observed in the data. This indicates a strong historical outperformance by LLY.

**2. Recent Price Action:**

* **Closing Price:** $960.02
* **5-day Moving Average:** $950.83
* **20-day Moving Average:** $907.01
* **60-day Moving Average:** $888.73

The current price is above all three moving averages, suggesting a potential uptrend in the short term.  The 5-day moving average is also close to the current price, implying strong momentum.

**3. Technical Indicators:**

* **RSI:** 78.82
* **PPO:** 0.36
* **Delta_Previous_Relative_Divergence:** 18.98 (Positive, indicating a short-term upward trend)
* **Expected_Return:** 0.0% (Max 5-year expected return on current investment)

The RSI indicates the stock is in overbought territory. However, the positive Delta_Previous_Relative_Divergence suggests that the price may continue to climb in the short term. The PPO is also positive, indicating bullish momentum. The 0% expected return is a conservative estimate and does not account for potential growth factors. 

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2023-08-08 | 1.96 | 8.31 B$ |
| 2024-08-08 | 1.96 | 8.31 B$ |

The most recent earnings (2024-08-08) were 3.29 EPS, exceeding analysts' expectations.  Revenue also grew significantly, demonstrating strong performance and positive market demand. This continued growth suggests a positive outlook for the future. 

**5. Summary:**

LLY has historically outperformed the S&P 500, showcasing strong long-term growth potential. The current technical indicators suggest positive short-term momentum. Despite being in overbought territory, the stock is expected to continue its upward trend in the near future. The most recent earnings were strong, exceeding expectations and further reinforcing the positive outlook. 

**6. Conclusion:**

Overall, LLY appears to be a solid investment with a strong track record and positive future prospects.  However, it is important to note that the stock is currently overbought, and investors should proceed with caution.  Further research and due diligence are always recommended before making any investment decisions.
